Dr. Yashar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 W Carson St
Torrance, CA 90502Phone+1 310-595-0333
Education & Training
Medical College of Georgia at Augusta UniversityClass of 2019
Certifications & Licensure
CA State Medical License 2022 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 21 citationsA validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphoma.Geoffrey Shouse, Andy Kaempf, Max J Gordon, Andy Artz, David Yashar
Blood Advances. 2023-07-25 - 4 citationsA phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple mye...David Yashar, Tanya M. Spektor, Daisy Martinez, Matthew Ghermezi, Regina A. Swift
Leukemia & Lymphoma. 2021-11-24 - 1 citationsValidity of 1% Hormonal Receptor Positivity Cutoff by the ASCO/College of American Pathologists Guidelines at the Georgia Cancer Center.Firas Kreidieh, Ramses F Sadek, Li Fang Zhang, Aaron Gopal, Jean-Pierre Blaize
JCO Precision Oncology. 2022-02-01
Journal Articles
- A phase 2 trial of the efficacy and safety of elotuzumab in combination with pomalidomide, carfilzomib and dexamethasone for high-risk relapsed/refractory multiple mye...David Yashar, Tanya M. Spektor, Daisy Martinez, Matthew Ghermezi, Regina A. Swift, Benjamin Eades, Gary Schwartz, Shahrooz Eshaghian, Stephen Lim, Robert Vescio & Jame..., Leukemia and Lymphoma, 11/24/2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
